Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
West Pharmaceutical Services, Inc. company logo
West Pharmaceutical Services, Inc. logo

West Pharmaceutical Services, Inc. (WST)

Profile

Company profile for West Pharmaceutical Services, Inc. (WST)
MetricValue
Full NameWest Pharmaceutical Services, Inc.
TickerNYSE: WST
ExchangeNYSE
SectorHealthcare
IndustryMedical Instruments & Supplies
CountryUnited States
IPO
Indexes
Websitewestpharma.com
Employees10,600

Key Metrics

West Pharmaceutical Services, Inc. Key Details
MetricDateValue
Price$275.23
Price, 1D Change-1.15%
Market Cap$20B
TTM Dividend Yield0.31%
PE Ratio40.77
Beta0.55
Revenue$3B
Revenue, 1Y Change-1.98%
EPS$6.69
EPS, 1Y Change-15.17%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
West Pharmaceutical Services, Inc. chart

Events

West Pharmaceutical Services, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-Dividend$0.22
Next Ex-Dividend$0.22
Last Split2:1
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

WST Estimates
MetricDateValue
EPS$6.69
EPS Estimate$7.10
EPS Est. Change+6.26%
Revenue$2.89B
Revenue Estimate$3.06B
Revenue Est. Change+5.93%
Current Price$275.23
Price Target-$350.00
Price Tgt. Change-+27.17%

🔒 Log In To Unlock Full Data

EPS

WST EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$7.99$7.88-1.37%
$6.63$6.69+0.77%
$7.10N/A+6.26%
$7.79N/A+16.54%
WST EPS reported versus estimate values chart

Revenue

WST revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$2.96B$2.95B-0.24%
$2.88B$2.89B+0.28%
$3.06BN/A+5.93%
$3.26BN/A+12.74%
WST revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

WST Performance
MetricDateValue
Price, 1Y-18.31%
Price, 3Y+18.38%
Market Cap, 1Y-18.71%
Market Cap, 3Y+14.93%
Revenue, 1Y-1.98%
Revenue, 3Y+2.19%
EPS, 1Y-15.17%
EPS, 3Y-22.93%

🔒 Log In To Unlock Full Data

Technical Indicators

WST Technical Indicators
MetricDateValue
Current Price$275.23
SMA 200$244.14
SMA 200 vs Price-11.30%
SMA 50$274.08
SMA 50 vs Price-0.42%
Beta0.55
ATR$7.40
14-Day RSI50.63
10-Day Volatility12.03%
1-Year Volatility56.08%

Dividends

WST Dividends
MetricDateValue
Last Paid$0.22
Upcoming$0.22
Dividend Yield0.29%
Total Dividend$0.81
Dividends Paid$59.10M
Payout Ratio12.00%

🔒 Log In To Unlock Full Data

Income & Profitability

WST Income & Profitability
MetricDateValue
Revenue$2.89B
EPS$6.69
Gross Profit$1.00B
Gross Margin34.65%
Operating Profit$594.60M
Operating Margin-44.80%
Net Income$492.70M
Net Margin17.03%
EBITDA$750.00M

🔒 Log In To Unlock Full Data

Financial Health

WST Financial Health
MetricDateValue
Debt To Equity0.11
Current Ratio2.79
Quick Ratio2.11
-
F-Score7
Altman Z-Score15.54

Valuations

WST Valuations
MetricDateValue
PE Ratio40.77
PS Ratio6.56
PB Ratio6.49
EV/EBITDA24.47
Enterprise ValueN/A-

Balance Sheet

WST Balance Sheet
MetricDateValue
Book Value$2.68B
Cash & Equivalents$484.60M
Total Assets$3.64B
Current Assets$1.54B
Total Liabilities$961.10M
Current Liabilities$550.40M
Total Debt$305.30M
Short Term Debt$18.80M
Accounts Payable$239.30M

Expenses

WST Expenses
MetricDateValue
Total Expenses$2.40B
Operating Expenses$407.60M
Cost Of Goods Sold$1.89B
SG&A$0.00
D&A$155.40M
Interest Expense$0.00
Income Tax$107.50M

Cash Flow

WST Cash Flow
MetricDateValue
CFO$653.40M
CFI-$378.70M
CFF-$622.60M
Capex$377.00M
Free Cash Flow$276.40M

Recent analyst updates

WST Recent analyst updates
MetricDateValue
Morgan Stanley
TD Cowen
Barclays→
UBS→
Keybanc→
Evercore ISI Group→
Barclays→
Rothschild & Co
UBS→
Evercore ISI Group→

Analyst sentiment

Sentiment over the past month
WST analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
WST institutional ownership distribution chart

Screeners with WST

Data Sources & References

  1. WST Official Website www.westpharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/105770/000010577025000093/0000105770-25-000093-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/105770/000010577025000013/0000105770-25-000013-index.htm
  4. List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
  5. WST Profile on Yahoo Finance finance.yahoo.com/quote/WST
  6. WST Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/wst

FAQ

  • What is the ticker symbol for West Pharmaceutical Services, Inc.?

    The ticker symbol for West Pharmaceutical Services, Inc. is NYSE:WST

  • Does West Pharmaceutical Services, Inc. pay dividends?

    Yes, West Pharmaceutical Services, Inc. pays dividends. The last payment was $0.22, with an ex-dividend date on November 12, 2025

  • What sector is West Pharmaceutical Services, Inc. in?

    West Pharmaceutical Services, Inc. is in the Healthcare sector

  • What industry is West Pharmaceutical Services, Inc. in?

    West Pharmaceutical Services, Inc. is in the Medical Instruments & Supplies industry

  • What country is West Pharmaceutical Services, Inc. based in?

    West Pharmaceutical Services, Inc. is headquartered in United States

  • When did West Pharmaceutical Services, Inc. go public?

    West Pharmaceutical Services, Inc. initial public offering (IPO) was on March 17, 1980

  • Is West Pharmaceutical Services, Inc. in the S&P 500?

    Yes, West Pharmaceutical Services, Inc. is included in the S&P 500 index

  • Is West Pharmaceutical Services, Inc. in the NASDAQ 100?

    No, West Pharmaceutical Services, Inc. is not included in the NASDAQ 100 index

  • Is West Pharmaceutical Services, Inc. in the Dow Jones?

    No, West Pharmaceutical Services, Inc. is not included in the Dow Jones index

  • When was West Pharmaceutical Services, Inc. last earnings report?

    West Pharmaceutical Services, Inc.'s most recent earnings report was on October 23, 2025

  • When does West Pharmaceutical Services, Inc. report earnings?

    The next expected earnings date for West Pharmaceutical Services, Inc. is February 12, 2026